Skip to content
PubMed This is a summary of 11 peer-reviewed journal articles Updated
Gynecology

Do You Need Asherman Syndrome Treatment Without Pregnancy?

At a Glance

If you are not trying to get pregnant, Asherman syndrome may not require surgery when you have no pain or trapped menstrual blood. Treatment may still be considered for blocked bleeding, cyclic pelvic pain, or to make future evaluation of abnormal uterine bleeding possible.

The short answer is no—you do not always have to treat Asherman syndrome if you have completed your family or do not plan to carry a future pregnancy. If you have no pelvic pain and no trapped menstrual blood, you and your doctor might choose to observe your condition rather than pursuing surgery [1] [2].

However, treatment is not exclusively for fertility. Depending on the severity of your scar tissue (intrauterine adhesions) and whether it is causing symptoms, there are medical reasons your doctor might still recommend clearing the uterine cavity.

Trapped Blood and Pelvic Pain (Hematometra)

In severe cases of Asherman syndrome, dense scar tissue can partially or completely block the uterine cavity or the cervix [3]. If you are still having menstrual cycles, the blood may not be able to exit your body. This condition, called hematometra, causes menstrual blood to become trapped inside the uterus [4].

Trapped blood can lead to severe, cyclic pelvic pain or secondary dysmenorrhea (painful periods that develop later in life) [1] [3]. If you are experiencing cyclic pain despite having little to no menstrual bleeding, surgery to remove the blockages (a hysteroscopic adhesiolysis) is often recommended to relieve the obstruction and resolve the pain [1].

When to seek care: If you develop new, severe, or worsening pelvic pain, fever, foul-smelling discharge, or heavy bleeding, seek prompt medical attention. These symptoms require evaluation and should not be self-diagnosed as simple scar tissue pain.

Evaluating Future Uterine Symptoms

While Asherman syndrome is not established as an independent risk factor for endometrial cancer, women can still develop precancerous cells or cancer in the uterus for other reasons [5] [6].

Routine screening for endometrial cancer is generally not recommended for women without symptoms. However, if a woman develops abnormal bleeding—especially after menopause—doctors must evaluate the uterus. They typically start with a transvaginal ultrasound to measure the thickness of the uterine lining, followed by an endometrial biopsy (taking a small tissue sample) for a definitive diagnosis [7] [8].

Extensive scar tissue can make these standard diagnostic tools technically difficult. Severe adhesions can prevent a biopsy instrument from entering the uterus or result in an inadequate tissue sample [9]. Because a sealed cavity can make future evaluation challenging, some specialists might discuss clearing the cavity if you have significant personal risk factors for endometrial cancer (such as obesity, diabetes, or a strong family history), though preventive surgery solely for this reason is not a universal standard [9] [8].

Weighing Observation vs. Surgery

If you have no pain and no signs of trapped blood on an ultrasound, deciding whether to have surgery involves weighing the potential benefits against the risks.

Observation: Choosing not to have surgery means monitoring your symptoms. This involves checking in with your doctor if you develop new cyclic pain, abnormal bleeding, or postmenopausal bleeding.

Surgery: Hysteroscopic adhesiolysis involves passing a camera and instruments through the cervix to cut away scar tissue. For patients not trying to conceive, the primary goal is to relieve pain or obstruction, not to restore fertility [1]. The procedure carries risks, including bleeding, infection, fluid overload, and puncturing the uterus (uterine perforation) [10] [11]. Furthermore, scar tissue frequently returns. Studies show that adhesions recur in roughly 27% of initially successful procedures, and the risk is even higher for severe cases [10]. Repeat procedures may be necessary to keep the cavity open.

Because of these nuances, your treatment plan should be highly personalized. It is best made in close consultation with a gynecologist or minimally invasive surgeon who can evaluate your specific anatomy, symptoms, and long-term health needs.

Common questions in this guide

Is treatment for Asherman syndrome required if I do not want another pregnancy?
Not always. If you have no pelvic pain, trapped menstrual blood, or other concerning symptoms, you and your doctor may choose observation instead of surgery. Treatment may still be advised if adhesions block the uterine cavity, cause symptoms, or make future evaluation of abnormal bleeding difficult.
What is hematometra, and how is it connected to Asherman syndrome?
Hematometra is menstrual blood trapped inside the uterus because scar tissue blocks the uterine cavity or cervix. It can cause severe cyclic pelvic pain, sometimes with little or no menstrual bleeding. A blockage causing pain may be treated with hysteroscopic adhesiolysis to open the passage.
Which symptoms should prompt me to seek medical care?
Seek prompt medical attention for new, severe, or worsening pelvic pain, fever, foul-smelling discharge, or heavy bleeding. These symptoms need evaluation and should not automatically be attributed to Asherman syndrome or uterine scar tissue.
How would doctors evaluate my uterus if abnormal bleeding develops later?
Doctors commonly begin with a transvaginal ultrasound to assess the uterine lining and may follow it with an endometrial biopsy, which examines a small tissue sample. Extensive adhesions can make it difficult to enter the uterus or obtain an adequate sample, especially when postmenopausal bleeding requires evaluation.
What are the risks of hysteroscopic adhesiolysis when fertility is not my goal?
The procedure can cause bleeding, infection, fluid overload, or a uterine perforation. Scar tissue can return after treatment; adhesions recur in roughly 27% of initially successful procedures, with higher risk in severe cases, so repeat procedures may be needed.
Could my endometrial cancer risk affect the decision to treat adhesions?
Asherman syndrome is not established as an independent risk factor for endometrial cancer, and routine screening is generally not recommended when there are no symptoms. Obesity, diabetes, or a strong family history may lead a specialist to discuss opening the cavity to facilitate future evaluation, but preventive surgery for this reason is not a universal standard.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Since I am not planning a future pregnancy, do my current symptoms and anatomy warrant surgical treatment, or is it safe to observe?
  2. 2.How severe is my scar tissue, and is there any sign of trapped blood (hematometra) on my imaging?
  3. 3.If I choose observation, what specific symptoms should prompt me to call your office or seek urgent care?
  4. 4.How would we evaluate my uterus if I were to develop abnormal or postmenopausal bleeding in the future?
  5. 5.Given my personal and family medical history, do you recommend treating the adhesions to facilitate future uterine evaluations?
  6. 6.If I choose to have surgery, what are the specific risks, and what is the likelihood that the scar tissue will return or require a repeat procedure?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (11)
  1. 1

    Asherman's syndrome: current perspectives on diagnosis and management.

    Dreisler E, Kjer JJ

    International journal of women's health 2019; (11()):191-198 doi:10.2147/IJWH.S165474.

    PMID: 30936754
  2. 2

    Hysteroscopic adhesiolysis: efficacy and safety.

    Sanad AS, Aboulfotouh ME

    Archives of gynecology and obstetrics 2016; (294(2)):411-6 doi:10.1007/s00404-016-4107-9.

    PMID: 27129970
  3. 3

    Clinico-hysteroscopic analysis of severe intrauterine adhesions among Nigerian infertile women.

    Ugboaja JO, Oguejiofor CB, Igwegbe AO

    The Pan African medical journal 2017; (28()):226 doi:10.11604/pamj.2017.28.226.13838.

    PMID: 29629012
  4. 4

    Asherman syndrome: Audit of a single-operator cohort of 423 cases.

    Vancaillie T, Chan K, Liu J, et al.

    The Australian & New Zealand journal of obstetrics & gynaecology 2020; (60(4)):574-578 doi:10.1111/ajo.13182.

    PMID: 32458458
  5. 5

    The Risk of Endometrial Cancer and Uterine Sarcoma Following Endometriosis or Pelvic Inflammatory Disease.

    Huang JY, Ma KS, Wang LT, et al.

    Cancers 2023; (15(3)) doi:10.3390/cancers15030833.

    PMID: 36765791
  6. 6

    Endometrial Cancer Incidence in Endometriosis and Adenomyosis.

    Hermens M, van Altena AM, Velthuis I, et al.

    Cancers 2021; (13(18)) doi:10.3390/cancers13184592.

    PMID: 34572823
  7. 7

    ACOG Committee Opinion No. 734: The Role of Transvaginal Ultrasonography in Evaluating the Endometrium of Women With Postmenopausal Bleeding.

    Obstetrics and gynecology 2018; (131(5)):e124-e129 doi:10.1097/AOG.0000000000002631.

    PMID: 29683909
  8. 8

    Endometrial Biopsy: Tips and Pitfalls.

    Williams PM, Gaddey HL

    American family physician 2020; (101(9)):551-556.

    PMID: 32352730
  9. 9

    The accuracy of endometrial sampling in women with postmenopausal bleeding: a systematic review and meta-analysis.

    van Hanegem N, Prins MM, Bongers MY, et al.

    European journal of obstetrics, gynecology, and reproductive biology 2016; (197()):147-55.

    PMID: 26748390
  10. 10

    Results of centralized Asherman surgery, 2003-2013.

    Hanstede MM, van der Meij E, Goedemans L, Emanuel MH

    Fertility and sterility 2015; (104(6)):1561-8.e1.

    PMID: 26428306
  11. 11

    The influence of the location and extent of intrauterine adhesions on recurrence after hysteroscopic adhesiolysis.

    Yang JH, Chen CD, Chen SU, et al.

    BJOG : an international journal of obstetrics and gynaecology 2016; (123(4)):618-23 doi:10.1111/1471-0528.13353.

    PMID: 25753391

This page is for informational purposes only and does not constitute medical advice about whether to treat Asherman syndrome. A gynecologist or minimally invasive surgeon should review your symptoms, imaging, and individual health risks.

Get notified when new evidence is published on Asherman syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.